156 related articles for article (PubMed ID: 21902077)
21. Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.
Steinbrook R
N Engl J Med; 2008 Nov; 359(19):1977-81. PubMed ID: 18987366
[No Abstract] [Full Text] [Related]
22. A NICE fallacy.
Quigley M
J Med Ethics; 2007 Aug; 33(8):465-6. PubMed ID: 17664304
[TBL] [Abstract][Full Text] [Related]
23. Evidence and values: paying for end-of-life drugs in the British NHS.
Chalkidou K
Health Econ Policy Law; 2012 Oct; 7(4):393-409. PubMed ID: 23079299
[TBL] [Abstract][Full Text] [Related]
24. Justice, Transparency and the Guiding Principles of the UK's National Institute for Health and Care Excellence.
Charlton V
Health Care Anal; 2022 Jun; 30(2):115-145. PubMed ID: 34750743
[TBL] [Abstract][Full Text] [Related]
25. Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?
Towse A
Br J Clin Pharmacol; 2010 Sep; 70(3):360-6. PubMed ID: 20716236
[TBL] [Abstract][Full Text] [Related]
26. [Cost-effectiveness--limits between optimization and rationing].
Ruof J; Schöffski O
Z Rheumatol; 1998 Oct; 57(5):340-4. PubMed ID: 9864843
[TBL] [Abstract][Full Text] [Related]
27. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
[TBL] [Abstract][Full Text] [Related]
28. Patient choice and mobility in the UK health system: internal and external markets.
Dusheiko M
Dev Health Econ Public Policy; 2014; 12():81-132. PubMed ID: 24864384
[TBL] [Abstract][Full Text] [Related]
29. Economic evaluation in support of national health policy: the case of The Netherlands.
Elsinga E; Rutten FF
Soc Sci Med; 1997 Aug; 45(4):605-20. PubMed ID: 9226785
[TBL] [Abstract][Full Text] [Related]
30. Patients' views of explicit rationing: what are the implications for health service decision-making?
Devlin N; Appleby J; Parkin D
J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
[TBL] [Abstract][Full Text] [Related]
31. Is the aim of the English health care system to maximize QALYs?
Shah K; Praet C; Devlin N; Sussex J; Appleby J; Parkin D
J Health Serv Res Policy; 2012 Jul; 17(3):157-63. PubMed ID: 22767891
[TBL] [Abstract][Full Text] [Related]
32. Some inconsistencies in NICE's consideration of social values.
Paulden M; O'Mahony JF; Culyer AJ; McCabe C
Pharmacoeconomics; 2014 Nov; 32(11):1043-53. PubMed ID: 25145802
[TBL] [Abstract][Full Text] [Related]
33. Health economic evaluation in England.
Raftery J
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):367-74. PubMed ID: 25444294
[TBL] [Abstract][Full Text] [Related]
34. Do NICE and CHI have no interest in safety? Opinion of the book NICE, CHI and the NHS reforms. Enabling excellence or imposing control?
Fletcher P
Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):167-76. PubMed ID: 11059357
[TBL] [Abstract][Full Text] [Related]
35. Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.
Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
Pain Physician; 2010; 13(1):E23-54. PubMed ID: 20119474
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation and decision making in the UK.
Buxton MJ
Pharmacoeconomics; 2006; 24(11):1133-42. PubMed ID: 17067197
[TBL] [Abstract][Full Text] [Related]
37. An analysis of NICE's 'restricted' (or 'optimized') decisions.
O'Neill P; Devlin NJ
Pharmacoeconomics; 2010; 28(11):987-93. PubMed ID: 20936882
[TBL] [Abstract][Full Text] [Related]
38. Using health outcomes data to inform decision-making: government agency perspective.
Taylor R
Pharmacoeconomics; 2001; 19 Suppl 2():33-8. PubMed ID: 11700787
[TBL] [Abstract][Full Text] [Related]
39. 'Fourth hurdle reviews', NICE, and database applications.
Paul JE; Trueman P
Pharmacoepidemiol Drug Saf; 2001; 10(5):429-38. PubMed ID: 11802589
[TBL] [Abstract][Full Text] [Related]
40. Perspectives on the National Institute for Health and Clinical Excellence's recommendations to use health technologies only in research.
Dhalla IA; Garner S; Chalkidou K; Littlejohns P
Int J Technol Assess Health Care; 2009 Jul; 25(3):272-80. PubMed ID: 19619345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
